RBC Capital downgraded Select Medical (SEM) to Sector Perform from Outperform with a price target of $16.50, down from $19, after the company agreed to be acquired by a consortium led by Executive Chairman and Co-founder Bob Ortenzio for $16.50 per share.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SEM:
- Select Medical to be acquired by consortium for $16.50 per share in cash
- Select Medical price target lowered to $19 from $20 at RBC Capital
- AI-Driven Third-Party Systems Pose Growing Operational and Data Risks for Select Medical
- Select Medical Balances Growth With Margin Pressures
- Select Medical Declares Quarterly Dividend Amid Solid Results